PDSB·70465T107·US·equity·Healthcare - Biotechnology-13D/G
PDSB (PDS BIOTECHNOLOGY CORP) is held by 24 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($399,489), BlackRock, Inc. ($335,199), BLAIR WILLIAM & CO/IL ($181,500). Net institutional sentiment: Mixed.
See how PDSB's score breaks down across 4 SEC sources
Showing 1-20 of 30
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer